Dr Daniel Cehic
MBBS MBA FICOS FCSANZ FRACP
Cardiologist & Chief Medical Officer - Cardiology
Special clinical interest in CardioOncology
About Dr Daniel Cehic
Dr Daniel Cehic is a general cardiologist with subspecialist training in Cardio-Oncology and Electrophysiology.
He graduated from medicine at the University of Adelaide in 1989 and trained at the Royal Adelaide Hospital in Adelaide, Australia and the John Radcliffe Hospital in Oxford, England. In 1997 he returned to Australia and commenced cardiology practice, in private practice and then also at the Royal Adelaide Hospital, where he was a Senior Visiting Cardiologist until 2008.
Since 2009 he has focused on improving patient care and outcomes in private practice and he has held various national positions at Advara HeartCare since that time including Chief Medical Officer of Cardiology since 2017.
Daniel has Fellowships from the Royal Australasian College of Physicians, Cardiac Society of Australia and New Zealand and the International Cardio-Oncology Society. He is also a member of the Clinical Oncology Society of Australia and has worked with EviQ to help establish protocols in the management of patients with pacemakers and defibrillators who are undergoing radiation therapy.
His active interests are in Cardio-Oncology, quality medicine and best clinical outcomes for patients.
- Fellow of the Royal Australasian College of Physicians
- Fellow of the Cardiac Society of Australia and New Zealand
- Fellow of the Clinical Oncology Society of Australia
- The Importance of Primary Care in Cardio-Oncology, 2021
- Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation , 2021
- Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society, 2021
- Sex differences in Cardiac electronic device implantation: Outcomes from an Australian multi-centre clinical quality registry, 2021
- Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group, 2020